Clinical evaluation of a beta-blocking agent in a single daily dose
Di Veroli, C.; Compagno, S.
La Clinica Terapeutica 101(6): 623-628
1982
ISSN/ISBN: 0009-9074 PMID: 6127182 Document Number: 191114
A cardioselective .beta.-blocking agent (atenolol) was tested clinically for an average period of 85 days. The drug brought about satisfactory reduction of arterial blood pressure without inducing relevant side effects.
Document emailed within 1 workday
Related Documents
Salmini, G.; Cione, R.; Oldrini, R. 1970: Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative Minerva Cardioangiologica 18(5): 311-315Belz, G.G.; Wintrich, R. 1984: Cardiac effects of a single daily dose of 0.15 mg and 0.20 mg of beta-methyldigoxin Zeitschrift für Kardiologie 73(1): 29-33
De Gaudemaris, R.; Battistella, P.; Siche, J.P.; Debru, J.L.; Blatier, J.F.; Mallion, J.M. 1986: Comparative study of the efficacy of captopril at a single daily dose of 100 mg and at a twice daily dose of 50 mg by measuring ambulatory pressure over 24 hours Postgraduate Medical Journal 62 Suppl. 1: 97-100
Hansson, L.; Henningsen, N.C.; Jameson, S.; Karlberg, B.E.; Westerlund, A.; Aberg, H. 1976: Clinical testing of a new beta blocking agent--atenolol--in hypertension Lakartidningen 73(34): 2741-2744
Lehner, J.P.; Simon, A.; Kehder, A.; Weiss, Y.; Tzincoca, C.; Safar, M. 1978: Evaluation of cardiac performance in the hypertensive patient. Effect of a beta-blocking agent: atenolol Archives des Maladies du Coeur et des Vaisseaux 71(10): 1107-1112
Neviani, V.; Tosi, P.; Prampolini, M.L. 1976: 1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases La Clinica Terapeutica 77(5): 451-458
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Bricaire, H.; Pandos 1971: Clinical study on the action of a beta blocking agent (LB 46) on some manifestations of hyperthyroidism and hypothyroidism La Presse Medicale 79(51): 2301-2304
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Srivastava, B.N.; Jain, P.C.; Vyas, G.P. 1972: A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial) Indian Heart Journal 24(Suppl 1): 203-204
Motolese, M. 1970: Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug Bollettino Chimico Farmaceutico 109(6): 363-368
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Gaillat, J.; Croize, J.; Bru, J.P.; Stahl, J.P.; Le Noc, P.; Micoud, M. 1986: Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy Pathologie-Biologie 34(5): 461-464
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Lindner, E. 1984: L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity Arzneimittel-Forschung 34(3): 270-276
Dal Palu, C. 1971: Sudden death during treatment by beta-blocking agent Annales de Cardiologie et d'Angeiologie 20(1): 69-70
Lewis, B.S.; Bakst, A.; Kitchiner, D.; Gotsman, M.S. 1973: Effectiveness of sectral (M and B 17803A) as a beta-blocking agent in man South African Medical Journal 47(27): 1181-1184
Ishii, M.; Komori, S.; Satoh, H.; Ohta, T.; Motomura, S.; Hashimoto, K. 1984: Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(3): 259-266
Guechot, C.; Bertrand, A.; Cramaille, P.; Teulon, J.M. 1988: Analytical profile of the new diuretic beta-blocking agent tienoxolol hydrochloride Arzneimittel-Forschung 38(5): 655-660
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40